Vicor price target raised to $285 from $245 at Roth Capital

Roth Capital raised the firm’s price target on Vicor (VICR) to $285 from $245 and keeps a Buy rating on the shares after its Q1 earnings beat. The firm is citing rising demand in growth and product and licensing sales, while noting that its orders were robust, with backlog up 75% at $301M, the analyst tells investors in a research note. Roth adds it is raising its estimates to reflect stronger demand visibility and expanded capacity for Vicor.